According to Calliditas Therapeutics's latest financial reports the company's current revenue (TTM) is $0.13 B. In 2022 the company made a revenue of $76.26 M an increase over the years 2021 revenue that were of $25.98 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.11 B | 52.62% |
2022 | $76.26 M | 193.52% |
2021 | $25.98 M | 26931.42% |
2020 | $0.09 M | -99.52% |
2019 | $19.86 M | |
2018 | N/A | |
2017 | N/A |